FIB is highly expressed in various tumor tissues such as melanoma, lung cancer, renal cell carcinoma, and breast cancer, while it is most significantly expressed in breast cancer and is an independent risk factor for the prognosis of breast cancer patients [23]. This evidence concerns the gene FBL and renal cell carcinoma.